Cargando…
Effects of high dose atorvastatin before elective percutaneous coronary intervention on highly sensitive troponin T and one year major cardiovascular events; a randomized clinical trial()
INTRODUCTION: Some studies have demonstrated that post-PCI elevated cardiac enzymes are associated with worse outcomes. In this study, we aimed to determine if high-dose treatment with atorvastatin before planned elective PCI reduces PMI or MACE at 1-year median follow-up. MATERIAL AND METHODS: Elig...
Autores principales: | Pourhosseini, HamidReza, Lashkari, Reza, Aminorroaya, Arya, Soltani, Danesh, Jalali, Arash, Tajdini, Masih |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6328087/ https://www.ncbi.nlm.nih.gov/pubmed/30671535 http://dx.doi.org/10.1016/j.ijcha.2018.12.003 |
Ejemplares similares
-
One-Year Outcome of Patients with Coronary Artery Ectasia Undergoing Percutaneous Coronary Intervention: Clinical Implications and Question Marks
por: Amirzadegan, Alireza, et al.
Publicado: (2020) -
Atomoxetine as an adjunct to nonpharmacological treatments for preventing vasovagal attacks in patients with recurrent vasovagal syncope: A pilot randomized-controlled trial
por: Tajdini, Masih, et al.
Publicado: (2021) -
Clinical Associations of Injuries Caused by Vasovagal Syncope: A Cohort Study From a Tertiary Syncope Unit
por: Tajdini, Masih, et al.
Publicado: (2022) -
Potential Role of Vitamin C Intracoronary Administration in Preventing Cardiac Injury After Primary Percutaneous Coronary Intervention in Patients with ST-Elevation Myocardial Infarction
por: Shafaei-Bajestani, Negar, et al.
Publicado: (2019) -
High-dose atorvastatin pretreatment could diminishes microvascular impairment in patients undergoing elective percutaneous coronary intervention
por: He, Gui-Xin, et al.
Publicado: (2013)